Janssen Pharmaceutical K.K. Opens R&D Center in Shanghai

Published: Feb 06, 2013

by Richard Daverman, PhD and Henry Ye

February 5, 2013 -- Janssen Pharmaceutical, a division of Johnson & Johnson, has officially opened its China R&D Center in Shanghai Fenglin Life Science Park. The lab is located in the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. It will collaborate with the SIOC, Fudan University School of Medicine and other institutions to conduct research into three major disease areas: immunology, oncology and infectious disease. More details....

Stock Symbol: (NYSE: JNJ)

Back to news